Skip to main content

Jasper Therapeutics, Inc.

JSPR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001788028

No open-market purchases or sales by Jasper Therapeutics, Inc. insiders were filed in the last 90 days; 45 institutions reported holding it in 13F filings for Q2 2026, worth $5.05M in total; no superinvestor holds it.

Other share classesJSPRW

Q1 2025 vs. Q4 2024

How the institutions holding Jasper Therapeutics, Inc. changed between Q4 2024 and Q1 2025.

All holders in Q1 2025All holders in Q4 2024

13F holders of JSPR: Q4 2024 compared with Q1 2025
MeasureQ4 2024Of which not filed for Q1 2025Q1 2025Change
Holders88269−17
Shares15.7M136.3K13.0M−2.47M (−15.9%)
Value$334.5M$2.91M$56.1M−$275.5M (−83.1%)

2 institutions that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (13)

Institutions that held Jasper Therapeutics, Inc. at the end of Q1 2025 but not at the end of Q4 2024.

Institutions new to JSPR in Q1 2025
InstitutionSharesValue% of portfolio
Nuveen, LLC102,268$439.8K0.00%
Bank of Montreal71,740$308.5K0.00%
Corton Capital Inc.26,382$113.4K0.38%
Millennium Management LLC25,939$111.5K0.00%
SEI Investments Co18,851$81.1K0.00%
Marex Group plc13,339$57.4K0.00%
Acadian Asset Management LLC10,708$46.0K0.00%
Crewe Advisors LLC3,100$13.3K0.00%
Federated Hermes, Inc.1,057$4.54K0.00%
Caitong International Asset Management Co., Ltd1,020$4.39K0.00%
National Bank of Canada40$1720.00%
Coldstream Capital Management Inc38$1640.00%
Rossby Financial, LCC2$90.00%

Sold out (30)

Institutions that held Jasper Therapeutics, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.

Not filed for Q1 2025 yet (2)

Institutions that held Jasper Therapeutics, Inc. at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding JSPR in Q4 2024 that haven't filed for Q1 2025
InstitutionShares, Q4 2024Value, Q4 2024
Nuveen Asset Management, LLC83,417$1.78M
Fernwood Investment Management, LLC52,897$1.13M